期刊文献+

清肺通窍汤对肺经伏热型变应性鼻炎的临床疗效观察 被引量:2

Clinical Observation on the Lung by the V-type Allergic Rhinitis Patients by Qingfei Tongqiao Tang
下载PDF
导出
摘要 目的探讨清肺通窍汤治疗肺经伏热型常年性变应性鼻炎患者的临床疗效。方法将符合肺经伏热型常年性变应性鼻炎患者60例,随机分成治疗组、对照组,每组各30例,治疗3个疗程,每个疗程10天,观察治疗前后白三烯C4含量变化及总体疗效分析。结果①治疗组和对照组在治疗常年性变应性鼻炎肺经伏热型患者总有效率分别为93.3%和86.6%,两组在疗程结束后的综合疗效比较有显著性差异(P<0.01)。②在血清白三烯C4水平方面,两组在治疗前后自身比较均有显著性差异(P<0.01),且治疗后治疗组和对照组比较有显著性差异(P<0.05)。结论中药清肺通窍汤能有效治疗肺经伏热型常年性变应性鼻炎,与其降低白三烯C4水平有关,是安全有效的中药制剂。 Objective To explore the effect of Qingfei Tongqiao Tang for the treat-ment of patients with Lung V-type heat allergic rhinitis.Methods 60 perennial allergic rhinitis patients of Lung V-type heat,were randomly divided into two groups,the treatment group and the control group.The treatment group and the control group of western medicine were both treated for 30 days,then to observe the effect of the two groups before and after treatment,and also to observe the change of LTC4 in serum.Results(1)The total effective rate of curative effect was 93.3% in treatment group,while 86.3% in control group.There was significant difference between two groups after treatment(P<0.01).(2) Both groups can reduce serum level of LTC4(P<0.01),and the difference between the treatment group and the control group was significant(P<0.01).Conclusions Qingfei Tongqiao Tang is effective in treating lung volt heat in PAR,it was related with which can promote serum level of LTC4.It is the safe effective drug of traditional Chinese medicine.
出处 《光明中医》 2012年第6期1110-1112,共3页 GUANGMING JOURNAL OF CHINESE MEDICINE
基金 福建省卫生厅中医药项目资助(NO.WZY0909)
关键词 变应性鼻炎 清肺通窍汤 白三烯C4 血清 临床研究 Allergic Rhinitis Qingfei Tongqiao Tang LTC4 /serum Research
  • 相关文献

参考文献4

二级参考文献17

共引文献1793

同被引文献44

  • 1顾之燕,董震.变应性鼻炎的诊治原则和推荐方案(2004年,兰州)[J].中华耳鼻咽喉头颈外科杂志,2005,40(3):166-167. 被引量:1705
  • 2韩德民,张罗,黄丹,武阳丰,董震,许庚,孔维佳,暴继敏,周兵,汪审清,王德辉,王秋萍.我国11个城市变应性鼻炎自报患病率调查[J].中华耳鼻咽喉头颈外科杂志,2007,42(5):378-384. 被引量:402
  • 3刘渡舟 苏宝刚.金匮要略诠释[M].天津:天津科学技术出版社,1984.180.
  • 4张弘,张小霞,李飞,刘亮.肺阳概念内涵、外延的厘定及肺阳虚[J].成都医学院学报,2006,1(1):58-65. 被引量:8
  • 5Bousquet J,KhahaevN,CruzA A,et al.Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization,GA2LEN and Aller Gen). Allergy,2008,63 (Supper 86):8-160.
  • 6van Cauwenberge P, Bachert C,Passalacqua G,et al.Consensus statement on the treatment of allergic rhinifis.AUergy 2000,55:116-134.
  • 7Brozek J L,Bousquet J,Baena-Cagnani C E,et al.Allergic Rhinitis and its impact on Asthma ( ARIA ) guidelines:2010 Revision .J Allergy Clin Immunol,2010,126:466-476.
  • 8Sheikh A,Hurwitz B,Shehata Y.House dust mite avoidance measures for perennial allergic rhinitis.Cochrane Database Syst Rev,2007,(1):CD001563.
  • 9Juniper E F,Stahl E,Doty R L,et al.Chnical outcomes and adverse effect monitoring in allergic rhinitis.J Allergy Clin Immunol,2005, 115(Suppl 1):$590-$413.
  • 10Jadad A R,Moore R A,Carroll D.Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin TriMs,1996,17(l): 1-12.

引证文献2

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部